Patent · US Active

Screening test for recognizing prostate diseases and apparatus and diagnosis substance for carrying out the test

US8386012B2 · kind B2 · utility

3Cited by

5References

11Claims

0Family size

Assignee

Siemens Aktiengesellschaft · DE

Inventors

Jens Fehre · Eschborn, DE
Ralf Nanke · Fairview Avenue, DE
Martin Stetter · St. Leon-Rot, DE

Key dates

Filing date	Jul 31, 2008
Grant date	Feb 26, 2013
Priority date	—
Expiry date	Jul 6, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K49/0004
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

In a screening test method, and a device for implementing the screening test method, a diagnostic substance is provided that contains at least one biomarker connected with at least one ferromagnetic particle, the biomarker binding specifically to a target molecule that is formed by specific pathological prostrate tissue. The diagnostic substance is administered to the blood stream of a patient. A magnetometer is used to detect enrichment of the ferromagnetic particle in the prostrate, as an indicator of a level of the specific pathological prostrate tissue.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.